Decision Diagnostics Stock Today

DECN Stock  USD 0.0001  0.00  0.00%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Over 85

 
High
 
Low
Very High
Decision Diagnostics is selling at 1.0E-4 as of the 18th of April 2024; that is No Change since the beginning of the trading day. The stock's open price was 1.0E-4. Decision Diagnostics has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Decision Diagnostics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 19th of January 2024 and ending today, the 18th of April 2024. Click here to learn more.
Business Domain
Health Care Equipment & Services
Category
Healthcare
Classification
Health Care
Decision Diagnostics Corp. develops smart phone based electronic medical record technologies. Decision Diagnostics Corp. was founded in 2000 and is based in Westlake Village, California. Decision Diagnostics operates under Pharmaceutical Retailers classification in the United States and is traded on OTC Exchange. The company has 357.87 M outstanding shares. More on Decision Diagnostics

Decision Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Decision Diagnostics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Decision Diagnostics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEOKeith Berman
Business ConcentrationHealth Care Technology, Health Care Equipment & Services, Health Care, Health Care, Health Care Technology, Pharmaceutical Retailers, Healthcare (View all Sectors)
Financial Strength
Based on the key indicators related to Decision Diagnostics' liquidity, profitability, solvency, and operating efficiency, Decision Diagnostics is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of Decision Diagnostics is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.380.4
Notably Down
Slightly volatile
Gross Profit Margin0.140.23
Way Down
Slightly volatile
Net DebtM2.2 M
Notably Down
Slightly volatile
Total Current Liabilities3.5 M5.7 M
Way Down
Slightly volatile
Non Current Liabilities Total196.1 K220.6 K
Fairly Down
Slightly volatile
Total Assets5.2 M6.5 M
Significantly Down
Slightly volatile
Total Current Assets2.5 M1.5 M
Way Up
Slightly volatile
Decision Diagnostics' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Decision Diagnostics' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Decision Diagnostics' financial leverage. It provides some insight into what part of Decision Diagnostics' total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Decision Diagnostics' books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Decision Diagnostics deploys its capital and how much of that capital is borrowed.
Liquidity
Decision Diagnostics cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 2.93 M in liabilities with Debt to Equity (D/E) ratio of 9.05, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Decision Diagnostics has a current ratio of 0.25, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Decision Diagnostics until it has trouble settling it off, either with new capital or with free cash flow. So, Decision Diagnostics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Decision Diagnostics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Decision to invest in growth at high rates of return. When we think about Decision Diagnostics' use of debt, we should always consider it together with cash and equity.

Total Cash From Operating Activities

(1.33 Million)
Decision Diagnostics (DECN) is traded on OTCCE Exchange in USA and employs 6 people. Decision Diagnostics is listed under Health Care Technology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 357. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Decision Diagnostics's market, we take the total number of its shares issued and multiply it by Decision Diagnostics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Decision Diagnostics conducts business under Health Care Technology sector and is part of Health Care industry. The entity has 357.87 M outstanding shares. Decision Diagnostics currently holds about 210.85 K in cash with (1.4 M) of positive cash flow from operations.
Check Decision Diagnostics Probability Of Bankruptcy

Decision Stock Against Markets

Picking the right benchmark for Decision Diagnostics stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Decision Diagnostics stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Decision Diagnostics is critical whether you are bullish or bearish towards Decision Diagnostics at a given time. Please also check how Decision Diagnostics' historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Decision Diagnostics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Top Crypto Exchanges Now

   

Top Crypto Exchanges

Search and analyze digital assets across top global cryptocurrency exchanges
All  Next Launch Module

How to buy Decision Stock?

Before investing in Decision Diagnostics, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Decision Diagnostics. To buy Decision Diagnostics stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Decision Diagnostics. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Decision Diagnostics stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Decision Diagnostics stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Decision Diagnostics stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Decision Diagnostics, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Decision Stock please use our How to Invest in Decision Diagnostics guide.

Already Invested in Decision Diagnostics?

The danger of trading Decision Diagnostics is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Decision Diagnostics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Decision Diagnostics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Decision Diagnostics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Decision Diagnostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Decision Diagnostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Decision Diagnostics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Decision Diagnostics Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Decision Diagnostics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.
Note that the Decision Diagnostics information on this page should be used as a complementary analysis to other Decision Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Decision Stock analysis

When running Decision Diagnostics' price analysis, check to measure Decision Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Decision Diagnostics is operating at the current time. Most of Decision Diagnostics' value examination focuses on studying past and present price action to predict the probability of Decision Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Decision Diagnostics' price. Additionally, you may evaluate how the addition of Decision Diagnostics to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Is Decision Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Decision Diagnostics. If investors know Decision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Decision Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.02)
Revenue Per Share
0.006
Quarterly Revenue Growth
(0)
Return On Assets
(0.21)
Return On Equity
(81.61)
The market value of Decision Diagnostics is measured differently than its book value, which is the value of Decision that is recorded on the company's balance sheet. Investors also form their own opinion of Decision Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Decision Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Decision Diagnostics' market value can be influenced by many factors that don't directly affect Decision Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Decision Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Decision Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Decision Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.